Lynn A. Fussner, MD, Assistant Professor at The Ohio State University (OSU), Division of Pulmonary, Critical Care, and Sleep Medicine, has been awarded a one-year grant from the Vasculitis Foundation (VF) for her study, “Role of Monocytes and Alpha-1 Antitrypsin in ANCA-Associated Vasculitis.” Dr. Fussner’s goal is to identify better…...
ANCA-associated Vasculitis
An August 2020 article in Nature Reviews discusses the many aspects of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)—a group of autoimmune diseases (granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, and microscopic polyangiitis) that causes blood vessels to swell. The vessels involved in AAV are typically capillaries, arterioles and venules but small…...
ChemoCentryx Announces Publication in The New England Journal of Medicine of Results of the Pivotal Phase III ADVOCATE Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
February 17, 2021 17:00 ET | Source: ChemoCentryx, Inc. — Treatment with avacopan in the absence of daily oral prednisone led to remission at week 26 and superiority in sustaining remission at 52 weeks compared to the prednisone group — — Avacopan’s effects on kidney function, patient Quality of Life,…...
Vasculitis Foundation’s Young Investigator Award Goes to Monash University Research Fellow
Dragana Odobasic, PhD, Research Fellow Monash University, Department of Medicine, Melbourne, Australia Study Title: “Tolerogenic Dendritic Cells for Antigen-Specific Immunosuppression in MPO-ANCA Vasculitis” Investigator: Dragana Odobasic, PhD Co-investigator: Stephen Holdsworth, MD, PhD, Professor, Monash University, Department of Medicine; Head, Clinical Immunology, Monash Health, Clayton, Victoria, Australia Institution: Monash University, Department of Medicine, Centre…...
VF Announces Young Investigator Award
Dragana Odobasic, PhD, a research fellow at Monash University in Melbourne, Australia, was awarded the Vasculitis Foundation’s (VF) “Dr. Chris Cox-Marinelli Young Investigator Award” in May for her study, Tolerogenic Dendritic Cells for Antigen-Specific Immunosuppression in MPO-ANCA Vasculitis. The award, a one-year grant totaling $49,822, was created in memory of…...
